← All companies

OPTH

Optimi Health Corp.

OPTH Nasdaq Pharmaceutical Preparations EDGAR ↗

$4.78

-0.07 -1.44%

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

$4.00 – $6.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Sep 23, 2026

6-K FORM 6-K Sep 22, 2026

6-K FORM 6-K Sep 16, 2026

6-K FORM 6-K Sep 10, 2026

6-K FORM 6-K Sep 8, 2026

6-K FORM 6-K Aug 27, 2026

6-K CURRENT REPORT Aug 14, 2026

6-K FORM 6-K Aug 14, 2026

6-K FORM 6-K Aug 7, 2026

6-K REPORT OF FOREIGN PRIVATE ISSUER Jul 28, 2026

6-K FORM 6-K Jul 20, 2026

6-K Jun 29, 2026

6-K Jun 16, 2026

6-K Jun 10, 2026

6-K Jun 8, 2026

6-K Jun 2, 2026

6-K Jun 2, 2026

6-K May 29, 2026

6-K May 26, 2026

Other filings

424B3 PROSPECTUS Aug 27, 2026

EFFECT Aug 25, 2026

F-1 REGISTRATION STATEMENT Aug 17, 2026

SCHEDULE 13G Aug 7, 2026

S-8 Jul 7, 2026

SCHEDULE 13G May 27, 2026

424B4 May 20, 2026

EFFECT May 19, 2026

CERT May 19, 2026

8-A12B May 19, 2026

F-1/A May 19, 2026

F-1/A Apr 23, 2026

F-1/A Apr 21, 2026

F-1/A Apr 21, 2026

F-1/A Apr 16, 2026

F-1/A Mar 24, 2026

F-1/A Mar 13, 2026

F-1/A Feb 17, 2026

F-1 Sep 5, 2025

DRS/A Aug 8, 2025

DRS Jun 16, 2025